Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery
NCT ID: NCT01893723
Last Updated: 2015-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
37 participants
INTERVENTIONAL
2012-06-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of NoL Index and ANI After Nociceptive Stimulation at Different Infusion Rates of Remifentanil Infusion
NCT02602379
Automatic Remifentanil Administration Guided by ANI During Propofol Anesthesia
NCT03556696
Prediction of Hemodynamic Reactivity During General Anesthesia Using Analgesia/Nociception Index (ANI)
NCT01839513
Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy
NCT00391885
Nociception Index Level (NOL) Perioperative Monitoring During Regional Anesthesia
NCT06300606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ANI guided remifentanil arm
remifentanil targets are increased or decreased depending on ANI readings. In case of high blood pressure associated with elevated ANI, nicardipine is administered.
ANI guided remifentanil
remifentanil administration during propofol anesthesia for laparoscopic surgery is ANI guided
ANI blind arm
remifentanil target is adapted as is usual during general anesthesia, depending on hemodynamic reactions to nociceptive surgical stimulations. In case of elevated blood pressure despite a maximum target of 10 ng/ml (Minto Pk/pD model), then nicardipine is administered.
ANI blind arm
remifentanil administration during propofol anesthesia for laparoscopic surgery is not ANI guided
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANI guided remifentanil
remifentanil administration during propofol anesthesia for laparoscopic surgery is ANI guided
ANI blind arm
remifentanil administration during propofol anesthesia for laparoscopic surgery is not ANI guided
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I or II
* adult patient
* body mass index between 17 and 33 kg/m2
Exclusion Criteria
* arrhythmia
* pace maker
* diabetes mellitus
* dysautonomia
* treatment with beta blocking agents
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mathieu JEANNE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Erasme (ULB)
Brussels, , Belgium
Clinique privée d'ANTONY
Antony, , France
University Hospital Claude Huriez
Lille, , France
University Hospital Roger Salengro
Lille, , France
University Hospital
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00947-34
Identifier Type: OTHER
Identifier Source: secondary_id
2010_51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.